MWM
EW icon

Meridian Wealth Management’s Edwards Lifesciences EW Stock Holding History

Meridian Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$262K Hold
2,900
– – 0.01% 710
2026
Q1 		$232K Buy
+2,900
New +$239K 0.01% 718

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Meridian Wealth Management's EW Position: Q2 2026 in Review

Meridian Wealth Management increased its Edwards Lifesciences (EW) stake by 0.17% in Q2 2026, buying an estimated $670 and bringing the position to 4,656 shares worth $421K. The position accounts for 0.01% of the portfolio, ranked #590.

Meridian Wealth Management first reported a position in EW in Q3 2018 and has held it in 26 quarters since. The position peaked at $1.49M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Meridian Wealth Management held 4,656 shares of Edwards Lifesciences worth $421K as of Q2 2026.
  • Meridian Wealth Management bought 8 Edwards Lifesciences shares in Q2 2026, an estimated $670.
  • Edwards Lifesciences made up 0.01% of Meridian Wealth Management's portfolio in Q2 2026, its #590 holding.
  • Meridian Wealth Management first reported a position in Edwards Lifesciences in Q3 2018 and has held it in 26 quarters since.
  • Meridian Wealth Management's Edwards Lifesciences position peaked at $1.49M in Q4 2021.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Meridian Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.